GENE ONLINE|News &
Opinion
Blog

Startups
Biodegradable Skin Staple! KMU Earned Major Recognition in the Annual Main Event of Plastic Surgery
2023-02-09
In-Home Kidney Disease Management Company, Monogram, Raises $375 Million
2023-01-13
Belharra Therapeutics Exits Stealth With $130 Million And A Genentech Deal
2023-01-05
Micronbrane Medical Aspires to Further Clinical Collaboration Following the Successful Series A Funding
2022-12-01Partner
Protect Bio, the Next Rising Star in the Blue Ocean Market of Companion Animals’ Healthcare
2022-11-29
Coastar Therapeutics Receives Venture Capital Investment to Further Develop Delivery Technology of Biologics for Cancer and Gene Therapies
2022-11-10Partner
Boston’s Manifold Bio Secures $40M to Tackle Translational Obstacles
2022-07-15
US Bio-Entrepreneur Program Launches in the UK
2022-06-30
Ultima Genomics Promises $100 Genome After Raising $600 Million
2022-06-01
REVEAL GENOMICS and Dana-Farber Cancer Institute Team Up to Research Breast Cancer
2022-04-29
Birmingham University Spinout Looking to Tackle Ocular Surface Disorders
2022-04-26
AACR 2022: Roadmap to a Successful Biotech Start-up Journey
2022-04-16
SeaX Ventures on $60 Million Journey to Aid Startups in Southeast Asia
2022-04-06
Cure or Poison? New Ventures Go IPO Continuously As “Psychedelics” Enter the Mental Health Market
2022-03-09
RumenEra Sets Out to Curb Gas by Researching Cows
2022-01-26
1 2 3 4
LATEST
Pfizer’s RSV Vaccine Gets FDA Approval for Use in Older Adults
2023-05-31
Brazil’s Evolving ESG Landscape from the Amazon to Atlantic Forest
2023-05-31
Should People Looking to Lose Weight Skip Sugar Substitutes?
2023-05-30
Advancing Next-Generation Cancer Metabolic Therapy by Targeting Critical Amino Acid Metabolic Pathways: An Interview with Brian A. Van Tine, MD, PhD
2023-05-26
Rona Therapeutics, Keymed Biosciences Team Up To Develop siRNA Drugs For Kidney Disease
2023-05-25
CDC Calls an End to J&J’s COVID-19 Vaccine in the U.S.
2023-05-25
A Close Look at the Evolution of ESG in Biopharma
2023-05-22
Scroll to Top